Titre (en)
Checkpoint
Istex
Racine
Checkpoint
Istex
Exploration
Accueil
Racine
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Checkpoint (Istex)

Index « Titre (en) » - entrée « inhibitor »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
inhibition < inhibitor < inhibitors  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000A17 (2007) Anne M. Landau [Canada] ; Edouard Kouassi [Canada] ; Rosmarie Siegrist-Johnstone [Canada] ; Julie Desbarats [Canada]Proteasome inhibitor model of Parkinson's disease in mice is confounded by neurotoxicity of the ethanol vehicle
000C88 (2005) Jean-Claude Tardif [Canada] ; Ian Ford [Royaume-Uni] ; Michal Tendera [Pologne] ; Martial G. Bourassa [Canada] ; Kim Fox [Royaume-Uni]Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable angina
001426 (1999) R. L. Sherry [Canada] ; R. T. Coutts [Canada] ; G. B. Baker [Canada]4‐fluorotranylcypromine, a novel monoamine oxidase inhibitor: Neurochemical effects in rat brain after short‐ and long‐term administration
001542 (1998) C. Thiffault [Canada] ; R. Quirion [Canada] ; J. Poirier [Canada]Effect of the MAO‐B inhibitor, MDL72974, on superoxide dismutase activity and lipid peroxidation levels in the mouse brain
001860 (1996) Amila Orucevic [États-Unis] ; Peeyush K. Lala [États-Unis]Effects of N G-methyl- L -arginine, an inhibitor of nitric oxide synthesis, on interleukin-2-induced capillary leakage and antitumor responses in healthy and tumor-bearing mice
001D27 (1993) M. Guttman [Canada] ; G. Léger [Canada] ; A. Reches [Israël] ; A. Evans [Canada] ; H. Kuwabara [Canada] ; J. M. Cedarbaum [États-Unis] ; J. M. Gjedde [Canada]Administration of the new COMT inhibitor OR‐611 increases striatal uptake of fluorodopa
001E20 (1992) Peter H. Yu [Canada] ; Dong-Mei Zuo [Canada]Inhibition of a type B monoamine oxidase inhibitor, (E)-2-(4-fluorophenethyl)-3-fluoroallylamine (MDL-72974A), on semicarbazide-sensitive amine oxidases isolated from vascular tissues and sera of different species
002892 (1977) G. Tunnicliff [Canada] ; T. T. Ngo [Canada] ; A. Barbeau [Canada]N-(5′-Phosphopyridoxyl)-4-aminobutyric acid: a stable bisubstrate adduct inhibitor of rat brain 4-aminobutyric acid aminotransferase

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i -k "inhibitor" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i  \
                -Sk "inhibitor" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Title.i
   |clé=    inhibitor
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022